Zhejiang Shengda Bio-Pharm Balance Sheet Health
Financial Health criteria checks 5/6
Zhejiang Shengda Bio-Pharm has a total shareholder equity of CN¥1.3B and total debt of CN¥238.4M, which brings its debt-to-equity ratio to 18.8%. Its total assets and total liabilities are CN¥1.7B and CN¥449.2M respectively.
Key information
18.8%
Debt to equity ratio
CN¥238.44m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥326.74m |
| Equity | CN¥1.27b |
| Total liabilities | CN¥449.20m |
| Total assets | CN¥1.72b |
Financial Position Analysis
Short Term Liabilities: 603079's short term assets (CN¥695.1M) exceed its short term liabilities (CN¥295.5M).
Long Term Liabilities: 603079's short term assets (CN¥695.1M) exceed its long term liabilities (CN¥153.7M).
Debt to Equity History and Analysis
Debt Level: 603079 has more cash than its total debt.
Reducing Debt: 603079's debt to equity ratio has reduced from 23% to 18.8% over the past 5 years.
Debt Coverage: 603079's debt is well covered by operating cash flow (27%).
Interest Coverage: Insufficient data to determine if 603079's interest payments on its debt are well covered by EBIT.